# Editas Medicine, Inc.: Form 8-K, filed Feb 25, 2021

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2021-02-25
- Accepted by EDGAR: Feb 25, 2021, 07:53 ET
- Period: 2021-02-25
- Accession: 0001558370-21-001723
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000155837021001723/edit-20210225x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000155837021001723/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000155837021001723/edit-20210225x8k.htm

Filed Feb 25, 2021.
Source: SEC EDGAR, the filing index for accession 0001558370-21-001723. Last ingested by Listed: Nov 14, 2026, 21:28 ET. No prices; not investment advice.
